A detailed history of Chilton Capital Management LLC transactions in Viatris Inc stock. As of the latest transaction made, Chilton Capital Management LLC holds 52 shares of VTRS stock, worth $619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52
Previous 52 -0.0%
Holding current value
$619
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$11.27 - $13.53 $586 - $703
52 New
52 $0
Q1 2023

May 15, 2023

BUY
$9.2 - $12.26 $2,162 - $2,881
235 New
235 $2,000
Q2 2022

Aug 16, 2022

BUY
$9.95 - $12.27 $87,410 - $107,791
8,785 New
8,785 $92,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $85,915 - $134,873
-8,758 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $105,884 - $128,567
8,758 New
8,758 $118,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.4B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.